Cencora Inc. (COR)
$292.36+1.89%
Spriggl Score: Moderate— sign in to explore; full breakdown with Premium
Last 30 trading days
Spriggl AI Verdict
“Specialty pivot lifts margins above distribution peers; oligopoly position sustains double-digit earnings growth.”
Sign up free to read the full investment thesis, bull case, bear case and what to watch.
About Cencora Inc.
Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment…
- Sector:
- Healthcare
- Industry:
- Medical Distribution
- Market Cap:
- $54.8B
Recent dividends
- 15 May 2026$0.60
- 13 Feb 2026$0.60
- 14 Nov 2025$0.60
Get the full Spriggl analysis — free
A free Spriggl account gets you the screener, a watchlist, AI verdicts and a free full report every day — across Cencora Inc. and 1,500+ UK and US stocks. The full score breakdown and AI analysis come with Premium.
Start free